Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.verified

FRTX

Price:

$0.9335

Market Cap:

$5.58M

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements...[Read more]

Industry

Biotechnology

IPO Date

1993-03-10

Stock Exchange

NASDAQ

Ticker

FRTX

The PE Ratio as of May 2024 (TTM) for Fresh Tracks Therapeutics, Inc. (FRTX) is -0.88

According to Fresh Tracks Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.88. This represents a change of 263.40% compared to the average of -0.24 of the last 4 quarters.

Fresh Tracks Therapeutics, Inc. (FRTX) Historical PE Ratio (quarterly & annually)

How has FRTX PE Ratio performed in the past?

The mean historical PE Ratio of Fresh Tracks Therapeutics, Inc. over the last ten years is -1.84. The current -0.88 PE Ratio has changed 4.68% with respect to the historical average. Over the past ten years (40 quarters), FRTX's PE Ratio was at its highest in in the September 2023 quarter at 0.68. The PE Ratio was at its lowest in in the September 2015 quarter at -35.25.

Quarterly (TTM)
Annual

Average

-1.84

Median

-1.25

Minimum

-5.65

Maximum

-0.17

Fresh Tracks Therapeutics, Inc. (FRTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Fresh Tracks Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 423.39%

Maximum Annual PE Ratio = -0.17

Minimum Annual Increase = -88.98%

Minimum Annual PE Ratio = -5.65

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.91347.78%
2022-0.20-56.38%
2021-0.47-48.90%
2020-0.91423.39%
2019-0.17-88.98%
2018-1.59-15.18%
2017-1.87-27.20%
2016-2.57-36.93%
2015-4.07-27.97%
2014-5.6572.32%

Fresh Tracks Therapeutics, Inc. (FRTX) Average PE Ratio

How has FRTX PE Ratio performed in the past?

The current PE Ratio of Fresh Tracks Therapeutics, Inc. (FRTX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.53

5-year avg

-0.53

10-year avg

-1.84

Fresh Tracks Therapeutics, Inc. (FRTX) PE Ratio vs. Peers

How is FRTX’s PE Ratio compared to its peers?

Fresh Tracks Therapeutics, Inc.’s PE Ratio is greater than Assembly Biosciences, Inc. (-1.55), less than Instil Bio, Inc. (-0.61), greater than Nuvation Bio Inc. (-10.56), less than Achilles Therapeutics plc (-0.59), less than NextCure, Inc. (-0.73), less than Comera Life Sciences Holdings, Inc. (-0.01), less than SAB Biotherapeutics, Inc. (-0.51), greater than Processa Pharmaceuticals, Inc. (-4.92), less than Third Harmonic Bio, Inc. (694.34), greater than Unicycive Therapeutics, Inc. (-0.98), less than Quoin Pharmaceuticals, Ltd. (-0.19), greater than Cardio Diagnostics Holdings, Inc. (-1.34), less than Virax Biolabs Group Limited (-0.22), less than PaxMedica, Inc. Common Stock (-0.10), less than SAB Biotherapeutics, Inc. (-0.51), less than Senti Biosciences, Inc. (-0.27), less than Cingulate Inc. (-0.18), less than Bellicum Pharmaceuticals, Inc. (-0.11), less than Hillstream BioPharma, Inc. (-0.00), less than Blue Water Vaccines, Inc. (-0.17), less than Revelation Biosciences, Inc. (-0.25), less than Kiora Pharmaceuticals, Inc. (5.27),

Build a custom stock screener for Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fresh Tracks Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fresh Tracks Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Fresh Tracks Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Fresh Tracks Therapeutics, Inc. (FRTX)?

What is the highest PE Ratio for Fresh Tracks Therapeutics, Inc. (FRTX)?

What is the 3-year average PE Ratio for Fresh Tracks Therapeutics, Inc. (FRTX)?

What is the 5-year average PE Ratio for Fresh Tracks Therapeutics, Inc. (FRTX)?

How does the current PE Ratio for Fresh Tracks Therapeutics, Inc. (FRTX) compare to its historical average?